Ipca Laboratories Limited
IPCALAB
Rang in aandelen
#3336
Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures... Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India, Europe, Africa, the Americas, Asia, the Commonwealth of Independent States, and Australasia. The company offers APIs in anti-hypertensive, anti-malarial, diuretic, DMARD, anti-hypertensive, and anthelmintic therapeutic areas. It also provides generic and branded formulations in various therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, diabetes, dermatology, diabetology, emollients/protectives, fever, gastroenterology, helminthics, hepatoprotectives, immunosuppressant, infectious diseases, malaria, neurology, neuropathic pain, and NSAIDs, as well as nutraceuticals, ophthalmology, oral anti diabetes drug, orthopedics, probiotics, psychiatry, respiratory, rheumatology, and urology. The company also exports its products worldwide. Ipca Laboratories Limited was incorporated in 1949 and is based in Mumbai, India.
Aandeelprijs
$20.48
Marktkapitalisatie
$5.20B
Verandering (1 dag)
-3.61%
Verandering (1 jaar)
40.68%
Land
IN
Handel Ipca Laboratories Limited (IPCALAB)
Categorie
Healthcare
Koersgeschiedenis voor Ipca Laboratories Limited (IPCALAB)
Hoogste slotkoers: $21.04 op 2026-10-01
Laagste slotkoers: $0.09 op 1996-01-01
Laagste slotkoers: $0.09 op 1996-01-01
Koersgeschiedenis van Ipca Laboratories Limited van 1996 tot 2026
Jaarlijkse koersprestatie
| Jaar | Prestaties |
|---|---|
| 2026 (TTM) | 11.56% |
| 2025 | -13.23% |
| 2024 | 38.48% |
| 2023 | 27.11% |
| 2022 | -23.07% |
| 2021 | -9.79% |
| 2020 | 89.81% |
| 2019 | 41.72% |
| 2018 | 27.54% |
| 2017 | 9.85% |
| 2016 | -29.56% |
| 2015 | -1.24% |
| 2014 | 3.97% |
| 2013 | 24.31% |
| 2012 | 74.85% |
| 2011 | -31.23% |
| 2010 | 70.55% |
| 2009 | 196.37% |
| 2008 | -55.33% |
| 2007 | 35.03% |
| 2006 | 33.17% |
| 2005 | -5.25% |
| 2004 | 46.12% |
| 2003 | 294.98% |
| 2002 | 90.18% |
| 2001 | -30.77% |
| 2000 | -57.08% |
| 1999 | 391.04% |
| 1998 | -1.48% |
| 1997 | 26.94% |
| 1996 | 0.00% |
Aandelenkoers van vergelijkbare bedrijven of concurrenten
| Bedrijf | Aandelenkoers | Verandering 1jr% | Land |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $161.15 | 20.52% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $212.49 | 24.09% |
CH
|
|
| $18.48 | -3.78% |
IN
|
